Loss of PRDM1/BLIMP-1 function contributes to poor prognosis for activated B-cell-like diffuse large B-cell lymphoma
Yi, X., et al. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis for activated B-cell-like diffuse large B-cell lymphoma
Yi, X., et al. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis for activated B-cell-like diffuse large B-cell lymphoma
Yi, X., et al. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis for activated B-cell-like diffuse large B-cell lymphoma. Leukemia. 2017 March; 31(3): 625-636.
Young K., et al. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma-is it necessary? Oncotarget 2015 June 10; 6(16): 13933-13945
PMID: 26101854
Chen L.Q., et al. Assessment of carbonic anhydrase IX expression and extracellular ph in B-cell lymphoma cell line models. Leuk Lymphoma. 2015 May; 56(5):1432–1439.
PMID: 25130478
Barr P.M., et al. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. Aug 2014 Vol 124:8.
PMID: 25016003
Rimsza L., et al. Accurate Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues. Clin Cancer Res. 2011 Jun 1:17(11)
PMID: 21364035
Rimsza L, et al. A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma. PLoS One. 2011;6(8):e22267.
PMID: 21829609
Rimsza L., et al. Gene Expression Predicts Overall Survival in Paraffin Embedded Tissues of Diffuse Large B Cell Lymphoma Treated with R-CHOP. Blood. 2008 Oct 15;112 (8):3425-3433.
PMID: 18544678
Roberts R., et al. Quantitative Nuclease Protection Assay in Paraffin-Embedded Tissue Replicates Prognostic Microarray Gene Expression in Diffuse Large B-Cell Lymphoma. Lab Invest. 2007 Oct;87(10):979-997.
PMID: 17700562
Page last updated May 22, 2023